Linghang Qu

871 total citations · 3 hit papers
26 papers, 666 citations indexed

About

Linghang Qu is a scholar working on Molecular Biology, Complementary and alternative medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Linghang Qu has authored 26 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Complementary and alternative medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Linghang Qu's work include Traditional Chinese Medicine Analysis (9 papers), Gut microbiota and health (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). Linghang Qu is often cited by papers focused on Traditional Chinese Medicine Analysis (9 papers), Gut microbiota and health (7 papers) and Cardiac Valve Diseases and Treatments (5 papers). Linghang Qu collaborates with scholars based in China, Pakistan and Russia. Linghang Qu's co-authors include Kang Xu, Yanju Liu, Lanqing Li, Chunli Wang, Shunshun Wang, Zijun Wang, Kang Xu, Haiying Xu, Guosheng Cao and Xianqiong Liu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Linghang Qu

23 papers receiving 662 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites

2023 121 citations Haiying Xu, Lanqing Li et al. Phytomedicine profile →
Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification

2024 58 citations Chunli Wang, Shunshun Wang et al. British Journal of Pharmacology profile →
Gut microbiota‐derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation

2025 36 citations Chunli Wang, Tingwen Zhou et al. iMeta profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Linghang Qu China	15	377	114	107	94	60	26	666
Ker Woon Choy Malaysia	14	293 0.8×	100 0.9×	81 0.8×	60 0.6×	61 1.0×	57	759
Liang Feng China	13	342 0.9×	74 0.6×	79 0.7×	63 0.7×	38 0.6×	34	659
Joo‐Hui Han South Korea	18	502 1.3×	57 0.5×	89 0.8×	72 0.8×	67 1.1×	46	928
Kwang Hoon Song South Korea	18	428 1.1×	144 1.3×	71 0.7×	71 0.8×	152 2.5×	37	882
Chao Lin China	15	260 0.7×	108 0.9×	56 0.5×	61 0.6×	60 1.0×	29	574
Judit Mihaly‐Bison Austria	10	308 0.8×	76 0.7×	107 1.0×	71 0.8×	43 0.7×	13	622
Dujuan Xu China	16	354 0.9×	118 1.0×	93 0.9×	128 1.4×	33 0.6×	33	661
Weifeng Huang China	17	351 0.9×	58 0.5×	102 1.0×	144 1.5×	63 1.1×	38	787
Cuizhu Wang China	16	482 1.3×	94 0.8×	51 0.5×	154 1.6×	44 0.7×	44	771
Linna Liu China	18	327 0.9×	89 0.8×	58 0.5×	88 0.9×	46 0.8×	56	726

Countries citing papers authored by Linghang Qu

Since Specialization

Citations

This map shows the geographic impact of Linghang Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghang Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghang Qu more than expected).

Fields of papers citing papers by Linghang Qu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linghang Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghang Qu. The network helps show where Linghang Qu may publish in the future.

Co-authorship network of co-authors of Linghang Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Linghang Qu. A scholar is included among the top collaborators of Linghang Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linghang Qu. Linghang Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Chaoyang, et al.. (2025). Integrating transcriptomics, metabolomics, and microbiomics to explore the mechanism of action of bran-fried Atractylodes lancea rhizome polysaccharide in ameliorating the enhanced pharmacological effects of dextran sodium sulfate-induced colitis. Journal of Ethnopharmacology. 349. 119805–119805.

Zhong, Lijie, et al.. (2025). β-Eudesmol in Rhizoma Atractylodis targets AVPR2 to inhibit the cAMP-AQP2 pathway and promote fluid metabolism. Phytomedicine. 145. 157035–157035.

Qu, Linghang, et al.. (2025). Rhizoma Atractylodis: a review on processing, chemical composition, pharmacological effects, and product development. 5(1). 115–130. 2 indexed citations

Wang, Chunli, Tingwen Zhou, Jiaqin Wu, et al.. (2025). Gut microbiota‐derived butyric acid regulates calcific aortic valve disease pathogenesis by modulating GAPDH lactylation and butyrylation. iMeta. 4(4). e70048–e70048. 36 indexed citations breakdown →

Guo, Dongmei, Kang Xu, Chaoyang Ma, et al.. (2024). Different processing methods and pharmacological effects of Atractylodis Rhizoma. Chinese Journal of Natural Medicines. 22(8). 756–768. 3 indexed citations

Shi, Kun, et al.. (2024). Atractylodin modulates ASAH3L to improve galactose metabolism and inflammation to alleviate acute lung injury. iScience. 27(10). 110751–110751. 3 indexed citations

Wang, Chunli, Shunshun Wang, Zijun Wang, et al.. (2024). Andrographolide regulates H3 histone lactylation by interfering with p300 to alleviate aortic valve calcification. British Journal of Pharmacology. 181(12). 1843–1856. 58 indexed citations breakdown →

Xu, Haiying, Lanqing Li, Shunshun Wang, et al.. (2023). Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine. 118. 154940–154940. 121 indexed citations breakdown →

Zheng, Yong, et al.. (2023). Dehydroevodiamine Targeting ACHE and ALDH3A1 Regulate Glycolytic Metabolism to Inhibit Hepatocellular Carcinoma Cell Apoptosis. Natural Product Communications. 18(8).

10.

Xu, Haiying, et al.. (2022). Quality assessment of processed Eucommiae Cortex based on the color and tensile force. Medicine in Novel Technology and Devices. 16. 100167–100167. 4 indexed citations

11.

Xu, Haiying, Lanqing Li, Linghang Qu, et al.. (2022). Atractylenolide‐1 affects glycolysis/gluconeogenesis by downregulating the expression of TPI1 and GPI to inhibit the proliferation and invasion of human triple‐negative breast cancer cells. Phytotherapy Research. 37(3). 820–833. 14 indexed citations

12.

Qu, Linghang, Kun Shi, Jing Xu, et al.. (2022). Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis. Phytomedicine. 98. 153945–153945. 48 indexed citations

13.

Wang, Zijun, Lanqing Li, Shunshun Wang, et al.. (2022). The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Frontiers in Pharmacology. 13. 1025860–1025860. 35 indexed citations

14.

Qu, Linghang, et al.. (2022). Preventive effect of Atractylodis Rhizoma extract on DSS-induced acute ulcerative colitis through the regulation of the MAPK/NF-κB signals in vivo and in vitro. Journal of Ethnopharmacology. 292. 115211–115211. 30 indexed citations

15.

Wang, Jie, Penghua Zhang, Jing Zhang, et al.. (2022). Atractylenolide-1 Targets FLT3 to Regulate PI3K/AKT/HIF1-α Pathway to Inhibit Osteogenic Differentiation of Human Valve Interstitial Cells. Frontiers in Pharmacology. 13. 899775–899775. 5 indexed citations

16.

Qu, Linghang, Chunlian Liu, Zhongshi Zhou, et al.. (2021). Atractylodin Attenuates Dextran Sulfate Sodium-Induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway. Frontiers in Pharmacology. 12. 665376–665376. 49 indexed citations

17.

Lei, Lin, Linghang Qu, Lin Xiong, et al.. (2021). Identification of different bran-fried Atractylodis Rhizoma and prediction of atractylodin content based on multivariate data mining combined with intelligent color recognition and near-infrared spectroscopy. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 262. 120119–120119. 19 indexed citations

18.

Wang, Chunli, Yi Xia, Linghang Qu, et al.. (2021). Cardamonin inhibits osteogenic differentiation of human valve interstitial cells and ameliorates aortic valve calcification via interfering in the NF-κB/NLRP3 inflammasome pathway. Food & Function. 12(23). 11808–11818. 29 indexed citations

19.

Qu, Linghang, Guosheng Cao, Kang Xu, et al.. (2020). Effects of Atractylodes Oil on Inflammatory Response and Serum Metabolites in Adjuvant Arthritis Rats. Biomedicine & Pharmacotherapy. 127. 110130–110130. 44 indexed citations

20.

Tu, Jiyuan, Ying Xie, Kang Xu, et al.. (2020). Treatment of Spleen-Deficiency Syndrome With Atractyloside A From Bran-Processed Atractylodes lancea by Protection of the Intestinal Mucosal Barrier. Frontiers in Pharmacology. 11. 583160–583160. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact